Who Owns Fulgent Genetics Stock?
NASDAQ: FLGTHealthcareDiagnostics & ResearchUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 58.41%
- Held by insiders
- 37.75%
- Institutional holders
- 217
- Institutions 58.4%
- Insiders 37.7%
- Public and other 3.8%
Who owns Fulgent Genetics stock?
Institutional investors own about 58.4% of Fulgent Genetics's shares, spread across 217 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 37.75% of FLGT.
The largest institutional holders are Blackrock Inc. (8.31%), Acadian Asset Management. LLC (3.70%) and Vanguard Capital Management LLC (2.87%). Together, the top 10 institutions control 31.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their FLGT positions and 6 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FLGT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 2.29M | 8.31% | -17.6% |
| Acadian Asset Management. LLC | 1.02M | 3.70% | -17.5% |
| Vanguard Capital Management LLC | 789.50K | 2.87% | -10.3% |
| Jacobs Levy Equity Management, Inc. | 782.12K | 2.84% | +119.5% |
| JPMORGAN CHASE & CO | 756.56K | 2.75% | +64.3% |
| Diametric Capital, Lp | 697.78K | 2.54% | +93.3% |
| Ameriprise Financial, Inc. | 670.08K | 2.44% | +18.9% |
| Dimensional Fund Advisors LP | 625.36K | 2.27% | -6.9% |
| Geode Capital Management, LLC | 521.01K | 1.89% | -10.8% |
| State Street Corporation | 498.67K | 1.81% | -5.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FLGT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 551.84K | 2.01% |
| iShares Trust-iShares Russell 2000 ETF | 506.33K | 1.84% |
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | 396.58K | 1.44% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 306.17K | 1.11% |
| NORTHERN LIGHTS FUND TRUST II-Invenomic Fund | 262.95K | 0.96% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 217.57K | 0.79% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 212.87K | 0.77% |
| iShares Trust-iShares Russell 2000 Value ETF | 176.79K | 0.64% |
| iShares Trust-iShares Biotechnology ETF | 136.21K | 0.50% |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF | 135.03K | 0.49% |
Frequently asked questions
Who is the largest shareholder of Fulgent Genetics?
Blackrock Inc. is the largest institutional shareholder of FLGT, owning 8.31% of shares outstanding (2.29M shares) as of its latest 13F filing.
What percentage of Fulgent Genetics is owned by institutions?
Institutions own about 58.4% of FLGT shares and 93.8% of the public float.
How much of Fulgent Genetics do insiders own?
Insiders, such as officers and directors, own about 37.75% of FLGT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.